Robert Hubbard - MetLife Independent Chairman of the Board
| METB34 Stock | BRL 495.39 0.00 0.00% |
Chairman
Dr. Robert Glenn Hubbard, Ph.D., is an Lead Independent Director of MetLife, Inc since 2019.
| Age | 61 |
| Tenure | 5 years |
| Professional Marks | Ph.D |
| Phone | 212 578 9500 |
| Web | https://www.metlife.com |
Robert Hubbard Latest Insider Activity
Tracking and analyzing the buying and selling activities of Robert Hubbard against MetLife stock is an integral part of due diligence when investing in MetLife. Robert Hubbard insider activity provides valuable insight into whether MetLife is net buyers or sellers over its current business cycle. Note, MetLife insiders must abide by specific rules, including filing SEC forms every time they buy or sell MetLife'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Robert Hubbard over two months ago Acquisition by Robert Hubbard of 903 shares of BlackRock Limited subject to Rule 16b-3 | ||
Robert Hubbard over two months ago Acquisition by Robert Hubbard of 871 shares of BlackRock Limited subject to Rule 16b-3 | ||
Robert Hubbard over two months ago Acquisition by Robert Hubbard of 918 shares of MetLife at 81.78 subject to Rule 16b-3 | ||
Robert Hubbard over three months ago Acquisition by Robert Hubbard of 903 shares of BlackRock Limited subject to Rule 16b-3 |
MetLife Management Efficiency
MetLife's management efficiency ratios could be used to measure how well MetLife manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 3 records | CHAIRMAN Age | ||
| Charles Lowrey | Prudential Financial | 65 | |
| Douglas McMillon | Walmart | 57 | |
| Robert CFA | Prudential Financial | 63 | |
Management Performance
| Return On Equity | 0.0538 | |||
| Return On Asset | 0.0034 |
MetLife Leadership Team
Elected by the shareholders, the MetLife's board of directors comprises two types of representatives: MetLife inside directors who are chosen from within the company, and outside directors, selected externally and held independent of MetLife. The board's role is to monitor MetLife's management team and ensure that shareholders' interests are well served. MetLife's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, MetLife's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Catherine Kinney, Independent Director | ||
| Randolph Clerihue, Chief Officer | ||
| Carlos Gutierrez, Independent Director | ||
| Pawan Verma, Executive Vice President, Chief Information Officer | ||
| Stephen Gauster, Senior Vice President Interim General Counsel | ||
| Ramy Tadros, Executive Vice President Chief Risk Officer | ||
| Michel Khalaf, President, Chief Executive Officer, Director | ||
| Bill Pappas, Executive Vice President Head of Global Technology and Operations | ||
| Diana McKenzie, Independent Director | ||
| Cheryl Grise, Lead Independent Director | ||
| John Hall, VP Relations | ||
| Robert Hubbard, Independent Chairman of the Board | ||
| William Kennard, Independent Director | ||
| Steven Goulart, Executive Vice President Chief Investment Officer | ||
| Susan Podlogar, Chief Human Resource Officer, Executive Vice President | ||
| David Herzog, Independent Director | ||
| Esther Lee, Executive Vice President, Global Chief Marketing Officer | ||
| Edward Kelly, Independent Director | ||
| Gerald Hassell, Independent Director | ||
| Oscar Schmidt, President of Latin America | ||
| Denise Morrison, Independent Director | ||
| Nuria Garcia, Head of EMEA | ||
| Marlene Debel, Executive Vice President, Chief Risk Officer | ||
| Mark Weinberger, Independent Director | ||
| John McCallion, Chief Financial Officer, Executive Vice President | ||
| Kishore Ponnavolu, President - Asia Region | ||
| John CPA, Ex CFO |
MetLife Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is MetLife a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0538 | |||
| Return On Asset | 0.0034 | |||
| Profit Margin | 0.04 % | |||
| Operating Margin | 0.06 % | |||
| Current Valuation | 413.71 B | |||
| Shares Outstanding | 779.1 M | |||
| Price To Earning | 60.42 X | |||
| Price To Book | 2.28 X | |||
| Price To Sales | 4.14 X | |||
| Revenue | 69.9 B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Information and Resources on Investing in MetLife Stock
When determining whether MetLife is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if MetLife Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Metlife Stock. Highlighted below are key reports to facilitate an investment decision about Metlife Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MetLife. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For information on how to trade MetLife Stock refer to our How to Trade MetLife Stock guide.You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.